Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow THC Therapeutics, Inc.

Get SEC filing alerts via email and in your feed for THC Therapeutics, Inc.

THCT

THC Therapeutics, Inc.

About THC Therapeutics, Inc.

THC Therapeutics, Inc. develops a patented, laboratory-proven herb dryer called the dHydronator® for drying and sanitizing cannabis, herbs, and tea leaves. The company focuses on wellness and nutraceutical markets, offering innovative solutions to reduce moisture and bacterial contamination efficiently. With patent protection and a prototype, it aims to commercialize its product through licensing, distribution, and strategic partnerships in the cannabis and herbal industries.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from THC Therapeutics, Inc.

1
1
THC Therapeutics, Inc. THC Therapeutics Reports Increased Net Loss and No Revenue for Fiscal Year Ending July 31, 2024

Via official filing (AI summary) | 4 months ago | 0 comments

2
1
THC Therapeutics, Inc. THC Therapeutics Reports Significant Changes in Revenue, Expenses, and Financial Performance in Latest Quarter

Via official filing (AI summary) | over 1 year ago | 0 comments